Mighty Therapeutics
Needham, US · 1 known investors
Find your way into Mighty Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
136 people can intro you to Reenie
Ask Ed Walters to introduce you to Reenie McCarthy
You →Ed · together at Morningside Technology Advisory LLC →Reenie
Sign up to find every way you can get introduced to Mighty Therapeutics
- Your email: who you already know at Mighty Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Mighty Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Mighty Therapeutics is a biopharmaceutical company developing mitochondria-targeted medicines to treat mitochondrial dysfunction in rare genetic mitochondrial diseases and common age-related conditions. Its pipeline spans rare genetic diseases, ophthalmic disorders, and neurological conditions, and it delivered the first approved therapy for Barth syndrome.
Founders & leadership
RM

Reenie McCarthyCEOReenie McCarthy spent over 20 years as a venture capital investor in biotechnology at Morningside before becoming CEO of Mighty Therapeutics, a biopharmaceutical company developing mitochondria-targeted medicines for rare genetic and age-related diseases.
Investors · 1
Frequently asked questions
- What does Mighty Therapeutics do?
- Mighty Therapeutics is a biopharmaceutical company developing mitochondria-targeted medicines to treat mitochondrial dysfunction in rare genetic mitochondrial diseases and common age-related conditions. Its pipeline spans rare genetic diseases, ophthalmic disorders, and neurological conditions, and it delivered the first approved therapy for Barth syndrome.
- Who are Mighty Therapeutics's investors?
- Mighty Therapeutics's investors include K2 HealthVentures.
- Where is Mighty Therapeutics headquartered?
- Mighty Therapeutics is headquartered in Needham, US.

